Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dudley W Lamming

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Cold Spring Harbor Perspectives in Medicine|April 7, 2016
Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and BeyondDudley W Lamming
Biorxiv : the Preprint Server for Biology|November 21, 2023
Quantification of healthspan in aging mice: Introducing FAMY and GRAILDudley W Lamming
Oncotarget|October 9, 2014
mTORC2 takes the longevity stAGEDudley W Lamming
Geroscience|May 13, 2026
Bench to bedside: is rapamycin headed for the docTOR?Dudley W Lamming
Springerplus|February 13, 2015
Diminished mTOR signaling: a common mode of action for endocrine longevity factorsDudley W Lamming
Geroscience|May 16, 2024
Quantification of healthspan in aging mice: introducing FAMY and GRAILDudley W Lamming
F1000Research|December 9, 2014
Hot topics at the intersection of aging and energetics: Diabetes/insulin resistance, Sirtuins, and the MicrobiomeDudley W Lamming
Translational Medicine of Aging|July 15, 2021
The regulation of healthspan and lifespan by dietary amino acidsReji Babygirija, Dudley W Lamming
Developmental Cell|March 22, 2022
The central moTOR of metabolismJudith Simcox, Dudley W Lamming
Geroscience|April 6, 2023
Geroprotective interventions in the 3xTg mouse model of Alzheimer's diseaseMichelle M Sonsalla, Dudley W Lamming
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Cold Spring Harbor Perspectives in Medicine|April 7, 2016
Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and BeyondDudley W Lamming
Biorxiv : the Preprint Server for Biology|November 21, 2023
Quantification of healthspan in aging mice: Introducing FAMY and GRAILDudley W Lamming
Oncotarget|October 9, 2014
mTORC2 takes the longevity stAGEDudley W Lamming
Geroscience|May 13, 2026
Bench to bedside: is rapamycin headed for the docTOR?Dudley W Lamming
Springerplus|February 13, 2015
Diminished mTOR signaling: a common mode of action for endocrine longevity factorsDudley W Lamming
Geroscience|May 16, 2024
Quantification of healthspan in aging mice: introducing FAMY and GRAILDudley W Lamming
F1000Research|December 9, 2014
Hot topics at the intersection of aging and energetics: Diabetes/insulin resistance, Sirtuins, and the MicrobiomeDudley W Lamming
Translational Medicine of Aging|July 15, 2021
The regulation of healthspan and lifespan by dietary amino acidsReji Babygirija, Dudley W Lamming
Developmental Cell|March 22, 2022
The central moTOR of metabolismJudith Simcox, Dudley W Lamming
Geroscience|April 6, 2023
Geroprotective interventions in the 3xTg mouse model of Alzheimer's diseaseMichelle M Sonsalla, Dudley W Lamming
Pageof 15